Nationwide Fund Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-30,965
| Closed | -$489K | – | 2212 |
|
|
2017
Q3 | $489K | Buy |
30,965
+3,037
| +11% | +$48K | ﹤0.01% | 2199 |
|
|
2017
Q2 | $347K | Buy |
27,928
+2,099
| +8% | +$26.1K | ﹤0.01% | 2367 |
|
|
2017
Q1 | $420K | Sell |
25,829
-1,681
| -6% | -$27.3K | ﹤0.01% | 2247 |
|
|
2016
Q4 | $415K | Buy |
27,510
+5,013
| +22% | +$75.6K | ﹤0.01% | 2274 |
|
|
2016
Q3 | $343K | Hold |
22,497
| – | – | ﹤0.01% | 2359 |
|
|
2016
Q2 | $873K | Buy |
22,497
+5,223
| +30% | +$203K | ﹤0.01% | 1816 |
|
|
2016
Q1 | $480K | Sell |
17,274
-67
| -0.4% | -$1.86K | ﹤0.01% | 2118 |
|
|
2015
Q4 | $933K | Buy |
17,341
+3,290
| +23% | +$177K | ﹤0.01% | 1769 |
|
|
2015
Q3 | $563K | Hold |
14,051
| – | – | ﹤0.01% | 2036 |
|
|
2015
Q2 | $449K | Buy |
14,051
+880
| +7% | +$28.1K | ﹤0.01% | 2308 |
|
|
2015
Q1 | $315K | Buy |
13,171
+239
| +2% | +$5.72K | ﹤0.01% | 2473 |
|
|
2014
Q4 | $228K | Sell |
12,932
-169
| -1% | -$2.98K | ﹤0.01% | 2557 |
|
|
2014
Q3 | $180K | Buy |
13,101
+177
| +1% | +$2.43K | ﹤0.01% | 2746 |
|
|
2014
Q2 | $218K | Buy |
+12,924
| New | +$218K | ﹤0.01% | 2709 |
|